|
SLC25A20 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.88440382689714E-11 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.59860014115054E-10 |
| Normal-vs-Stage2 |
9.11149999893723E-08 |
| Normal-vs-Stage3 |
7.88650256211554E-11 |
| Normal-vs-Stage4 |
2.68951527715444E-12 |
| Stage1-vs-Stage2 |
6.837600E-01 |
| Stage1-vs-Stage3 |
9.907900E-02 |
| Stage1-vs-Stage4 |
1.402270E-04 |
| Stage2-vs-Stage3 |
4.247800E-01 |
| Stage2-vs-Stage4 |
1.085720E-02 |
| Stage3-vs-Stage4 |
3.599500E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.20489951349612E-10 |
| Normal-vs-AfricanAmerican |
9.0205620750794E-13 |
| Normal-vs-Asian |
4.121600E-03 |
| Caucasian-vs-AfricanAmerican |
5.480400E-02 |
| Caucasian-vs-Asian |
7.804000E-01 |
| AfricanAmerican-vs-Asian |
2.845200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.8083979586313E-11 |
| Normal-vs-Female |
1.42680000037032E-08 |
| Male-vs-Female |
7.598000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.10030000000094E-06 |
| Normal-vs-Extreme_Weight |
1.6903145549918E-12 |
| Normal-vs-Obese |
9.69549995843977E-11 |
| Normal-vs-Extreme_Obese |
1.190600E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.454400E-01 |
| Normal_Weight-vs-Obese |
9.469000E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.994810E-01 |
| Extreme_Weight-vs-Obese |
8.498200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
1.179180E-01 |
| Obese-vs-Extreme_Obese |
6.551700E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.72746999999029E-05 |
| Normal-vs-Age(41-60Yrs) |
1.25879973111864E-10 |
| Normal-vs-Age(61-80Yrs) |
1.48180023806788E-10 |
| Normal-vs-Age(81-100Yrs) |
3.47119999999368E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.092000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.275400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.565000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.901400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.075400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.785600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.84350362437181E-11 |
| Normal-VS-Type2 PRCC |
1.52449999957227E-07 |
| Normal-VS-KIRP CIMP |
2.9096000053741E-09 |
| Normal-VS-Unclassified PRCC |
2.24740004384216E-10 |
| Type1 PRCC-VS-Type2 PRCC |
4.831400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.118950E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
5.934000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
8.350300E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
3.073000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.099900E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.55399998319683E-09 |
| Normal-vs-N1 |
7.32303107042753E-13 |
| Normal-vs-N2 |
3.004600E-04 |
| N0-vs-N1 |
2.683600E-02 |
| N0-vs-N2 |
5.122600E-01 |
| N1-vs-N2 |
6.755000E-01 |
|
|
